Patent · US Active

Imidazothiazole derivatives having proline ring structure

US8404691B2 · kind B2 · utility

0Cited by

0References

11Claims

0Family size

Assignee

DAIICHI SANKYO COMPANY, LIMITED · JP

Inventors

Kouichi Uoto · Tokyo, JP
Yuuichi Sugimoto · Tokyo, JP
Hiroyuki Naito · Tokyo, JP
Masaki Miyazaki · Chiba, JP
Keisuke Yoshida · Tokyo, JP
Masashi Aonuma · Tokyo, JP

Key dates

Filing date	Jul 15, 2011
Grant date	Mar 26, 2013
Priority date	—
Expiry date	Jul 15, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is provided compounds that inhibit interaction between murine double minute 2 (Mdm2) protein and p53 protein and exhibits anti-tumor activity. Compounds include imidazothiazole derivatives that can inhibit interaction between Mdm2 protein and p53 protein and exhibits anti-tumor activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.